A 2-Arm Randomized Controlled Trial of Concurrent Chemo-Radiotherapy Comparing Twice-Daily and Once-Daily Radiation Therapy Schedules in Patients With Limited Stage Small Cell Lung Cancer (SCLC) and Good Performance Status [CONVERT]
RATIONALE: Drugs used in chemotherapy, such as cisplatin and etoposide, work in different
ways to stop the growth of tumour cells, either by killing the cells or by stopping them from
dividing. Radiation therapy uses high-energy x-rays to kill tumour cells. It is not yet known
which schedule of radiation therapy is more effective when given together with chemotherapy
in treating small cell lung cancer.
PURPOSE: This randomized phase III trial is studying two different schedules of radiation
therapy to compare how well they work when given together with cisplatin and etoposide in
treating patients with limited stage small cell lung cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society